4.37
4.37 (0%)
As of Feb 14, 2025
Koru Medical Systems, Inc. [KRMD]
Source:
Company Overview
KORU Medical develops, manufactures and commercializes innovative and patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market as governed by the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international standards for quality system management.
| Country | United States |
| Headquarters | mahwah, new jersey |
| Phone Number | ( 845 )- 469-2042 |
| Industry | manufacturing |
| CEO | Linda Tharby |
| Website | www.korumedical.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $33.6 |
| Operating Profit | $-6.4 |
| Net Income | $-6.1 |
| Net Cash | $-1.9 |
Profit Ratios
| Gross Margin | $21.3 |
| Operating Margin | -19.2 |
| Profit as % of Revenues | -351.6% |
| Profit as % of Assets | -21.8% |
| Profit as % of Stockholder Equity | -36.1% |
Management Effectiveness
| Return on Equity | -36.1% |
| Return on Assets | -22.3% |
| Turnover Ratio | 120.9% |
| EBITA | $-5.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $27.2 |
| Total Liabilities | $10.4 |
| Operating Cash Flow | $-0.3 |
| Investing Cash Flow | $-1.3 |
| Financing Cash Flow | $-0.2 |
